Laboratory monitoring to reduce adverse drug-related events: a mixed methods study

BACKGROUND: Therapy with angiotensinconverting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) requires laboratory monitoring to avoid hyperkalemia and acute kidney failure. OBJECTIVE: To assess the frequency of recommended annual serum potassium and creatinine monitoring and dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Teresa N, Reynolds, Kristi, Hahn, Erin E, Munoz-Plaza, Corrine E, Yi, David K, Fischer, Heidi, Luong, Tiffany Q, Sim, John J, Brettler, Jeffrey, Handler, Joel, Mittman, Brian S, Singh, Hardeep, Kanter, Michael H, Danforth, Kim N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398702/
https://www.ncbi.nlm.nih.gov/pubmed/34949121
http://dx.doi.org/10.18553/jmcp.2022.28.1.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398702/
https://www.ncbi.nlm.nih.gov/pubmed/34949121
http://dx.doi.org/10.18553/jmcp.2022.28.1.16

Ejemplares similares